Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

Adjunctive Depot Antipsychotic in Treatment-Resistant Schizophrenia

By  

Current Psychopharmacology, Vol. 5, Iss. 1, 2016-06 ,pp. : 20-27

Bentham Science Publishers

Access to resources Recommend Favorite

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

By Bitter I.   Dossenbach M.R.K.   Brook S.   Feldman P.D.   Metcalfe S.   Gagiano C.A.   Furedi J.   Bartko G.   Janka Z.   Banki C.M.   Kovacs G.   Breier A.   for the Olanzapine HGCK Study Group  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

Combination of ''atypical'' antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder

By Lerner V.   Libov I.   Kotler M.   Strous R.D.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 89-98

Elsevier

Access to resources Recommend Favorite

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite